Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

52.18%

Threshold

Crossed downwards

Timeline

Published

05.12.2023

Transaction

27.11.2023

Voting rights breakdown

Voting rights acquired33.04%
Voting rights sold52.18%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TANBU000D2

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

On November 27, 2023, the exercise price of 12'736'209 call options has been reduced from CHF 0.13 to CHF 0.043. Of these call options,12,527,235 have been exercised and 208,974 remain outstanding.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open